Oral Oncology Volume 100 to 111

Oral Oncology is a highly regarded international interdisciplinary journal that focuses on publishing high-quality original research, clinical trials, review articles, editorials, and commentaries in the field of neoplasms (cancerous growths) occurring in the head and neck region. The journal covers a wide range of topics related to the etiology, epidemiology, prevention, clinical features, diagnosis, treatment, and management of these neoplasms.

The content of Oral Oncology is relevant and valuable to various professionals involved in the care and treatment of patients with head and neck neoplasms. This includes head and neck surgeons, radiation and medical oncologists, maxillofacial surgeons, otorhinolaryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists, counselors, professionals in end-of-life care, and others interested in these fields.

The journal welcomes high-quality original research, translational research, clinical research, and review papers that contribute to new knowledge in the field. The specific aspects of neoplasms arising in the head and neck region covered by the journal include various sites such as the lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, craniofacial region, and related hard and soft tissues and lymph nodes.

The journal encourages submissions on the following aspects related to head and neck neoplasms:

• Etiopathogenesis: Understanding the natural history of cancer and pre-cancerous conditions, basic pathology, metastatic mechanisms, genetic changes, cellular and molecular changes, microorganisms, growth factors, adhesion molecules, and other relevant factors.
• Epidemiology: Exploring risk factors, biomarkers, protective factors, geographic factors, prevention strategies, screening approaches, and intervention methods.
• Clinical features: Examining the local and distant effects of neoplasms on the orofacial region, tumor staging, and grading.
• Diagnosis: Discussing the detection of cancer and pre-cancerous conditions, cellular and molecular markers for diagnosis, advances in imaging techniques, and other functional diagnostic modalities.
• Management and prognosis: Evaluating clinical, cellular, and molecular markers for prognosis, treatment options (surgical, laser, photodynamic therapy, cryosurgery, micro-vascular surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy), molecular targets, new therapeutics, multimodality treatment approaches, reconstruction and rehabilitation advancements, and the importance of multidisciplinary teamwork in cancer care and oral health care.
• Quality of life issues: Addressing consent-related matters, psychosocial aspects, patient and health professional information, patient involvement, psychological interventions, improving outcomes, prevention, diagnosis, and management of complications, rehabilitation, palliative and end-of-life care, support teamwork, and other relevant topics.

Oral Oncology aims to provide comprehensive coverage of these areas, contributing to the understanding and management of neoplasms in the head and neck region. The journal serves as a valuable resource for professionals involved in the care and research of patients with head and neck cancer, promoting interdisciplinary collaboration and enhancing patient outcomes.